FDA.reportPublic FDA data

fenofibrate 30 MG Oral Capsule

RxCUI
1442163
RxNorm name
fenofibrate 30 MG Oral Capsule
Display name
fenofibrate 30 MG Oral Capsule
Full name
fenofibrate 30 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AntaraFENOFIBRATELupin Pharmaceuticals, Inc.12ebf783-64df-4ffa-9e84-f8fdf4d245d42024-08-20Warnings, Adverse reactionsExact identifier
rxcui: 1442163

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
12ebf783-64df-4ffa-9e84-f8fdf4d245d4fenofibrate 30 MG Oral CapsulePSN16These highlights do not include all the information needed to use ANTARA® safely and effectively. See full prescribing information for ANTARA. ANTARA (fenofibrate) capsules, for oral use Initial U.S. Approval: 199320240820
12ebf783-64df-4ffa-9e84-f8fdf4d245d4fenofibrate 30 MG Oral CapsuleSCD16These highlights do not include all the information needed to use ANTARA® safely and effectively. See full prescribing information for ANTARA. ANTARA (fenofibrate) capsules, for oral use Initial U.S. Approval: 199320240820